Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2161 - 2168 of 11454 results
Entirely Virtual Shareholder & Member Meetings Now Permitted in New York
November 23, 2021| Blog| Viewpoint
Robbins: GOP Continues Descent by Bullying Saule Omarova
November 23, 2021| News
USCIS Conducts Third H-1B Cap Lottery
November 22, 2021| Alert| Viewpoint
Discretion Retained: USPTO Dodges Attack from Big Tech to Rein in Discretionary IPR Denials
November 22, 2021| Blog| Viewpoint
Who’s in Charge Here? Federal Circuit Says An Arbitrator, not District Court, Should Decide Arbitrability
November 22, 2021| Blog| Viewpoint
About Face: Laboratory-Developed Tests for COVID-19 Now Subject to EUA Requirements
November 19, 2021| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.